Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physiologic Determinants of PPI Disposition in Children
NCT04248335Phase 4Completed
- Sponsor
- Children's Mercy Kansas City
- Start
- Jul 2018
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lansoprazole, pantoprazole, midazolam in gastroesophageal reflux disease (GERD), sponsored by Children's Mercy Kansas City. Started Jul 2018; status: completed.
02
Drugs
lansoprazolepantoprazolemidazolam
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT04248335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04248335.